A/Prof Kristen Radford is a Senior Research Fellow and NHMRC CDA Level 2 fellow. She completed her PhD in 1997 from the University of Newcastle, NSW and was awarded NSW Young Australian of the Year in 1998. She then undertook a postdoctoral position at Imperial Cancer Research Fund, London (now Cancer Research UK) developing new dendritic cell-based vaccine strategies for cancer immunotherapy. She joined Mater Research in 2001 and played a key role in obtaining the preclinical data that justified the first blood dendritic cell vaccine trial in prostate cancer that was completed in 2009. Her research interests are focussed on understanding basic dendritic cell biology in humans and applying this knowledge to develop more potent cancer vaccines.
Areas of expertise:
Techniques used / available:
Journal Article: Alpha cell receptor for advanced glycation end products associate with glucagon expression in type 1 diabetes
Leung, Sherman S., Lenchik, Nataliya, Mathews, Clayton, Pugliese, Alberto, McCarthy, Domenica A., Le Bagge, Selena, Ewing, Adam, Harris, Mark, Radford, Kristen J., Borg, Danielle J., Gerling, Ivan and Forbes, Josephine M. (2023). Alpha cell receptor for advanced glycation end products associate with glucagon expression in type 1 diabetes. Scientific Reports, 13 (1) 12948, 1-15. doi: 10.1038/s41598-023-39243-x
Journal Article: High dimensional analysis reveals distinct NK cell subsets but conserved response to stimulation in umbilical cord blood and adult peripheral blood
Buckle, Irina, Johnson, Anthony, Rojas, Ingrid Leal, Weinert, Vicky, Sester, David P., Radford, Kristen and Guillerey, Camille (2023). High dimensional analysis reveals distinct NK cell subsets but conserved response to stimulation in umbilical cord blood and adult peripheral blood. European Journal of Immunology, 53 (6) 2250118, 1-13. doi: 10.1002/eji.202250118
Journal Article: CD4+ T cell calibration of antigen-presenting cells optimizes antiviral CD8+ T cell immunity
Gressier, Elise, Schulte-Schrepping, Jonas, Petrov, Lev, Brumhard, Sophia, Stubbemann, Paula, Hiller, Anna, Obermayer, Benedikt, Spitzer, Jasper, Kostevc, Tomislav, Whitney, Paul G., Bachem, Annabell, Odainic, Alexandru, van de Sandt, Carolien, Nguyen, Thi H. O., Ashhurst, Thomas, Wilson, Kayla, Oates, Clare V. L., Gearing, Linden. J., Meischel, Tina, Hochheiser, Katharina, Greyer, Marie, Clarke, Michele, Kreutzenbeck, Maike, Gabriel, Sarah S., Kastenmüller, Wolfgang, Kurts, Christian, Londrigan, Sarah L., Kallies, Axel, Kedzierska, Katherine ... Bedoui, Sammy (2023). CD4+ T cell calibration of antigen-presenting cells optimizes antiviral CD8+ T cell immunity. Nature Immunology, 24 (6), 979-990. doi: 10.1038/s41590-023-01517-x
New immunotherapeutics for Acute Myeloid Leukemia
(2021–2022) TdC Senior Research Grant
New strategies to alleviate the effects of chemotherapy in children with leukemia
(2020–2022) The Children's Hospital Foundation
Novel human preclinical tools to better predict outcomes for immunotherapy
(2020–2022) Children's Hospital Foundation Immunotherapy Research Grants
Development of novel vaccines for cancer immunotherapy
Doctor Philosophy
Establishing Humanized Mouse Models to Evaluate Immunotherapy
(2022) Doctor Philosophy
Human dendritic cell immunoprofiling in advanced melanoma patients and responses to immunotherapy
(2019) Doctor Philosophy
Unexplored horizons of cDC1 in immunity and tolerance
Balan, Sreekumar, Radford, Kristen J. and Bhardwaj, Nina (2020). Unexplored horizons of cDC1 in immunity and tolerance. Advances in Immunology. (pp. 49-91) San Diego, CA United States: Academic Press. doi: 10.1016/bs.ai.2020.10.002
Monitoring dendritic cell activation and maturation
Macri, Christophe, Fancke, Ben, Radford, Kristen J. and O’Keeffe, Meredith (2019). Monitoring dendritic cell activation and maturation. Antigen Processing. (pp. 403-418) edited by Peter van Endert. New York, NY, United States: Humana Press. doi: 10.1007/978-1-4939-9450-2_28
The role of dendritic cells in cancer
Lee, Yoke Seng and Radford, Kristen J. (2019). The role of dendritic cells in cancer. Immunobiology of Dendritic Cells. Part A. (pp. 123-178) edited by Claire Lhuillier and Lorenzo Galluzzi. Cambridge, MA, United States: Academic Press. doi: 10.1016/bs.ircmb.2019.07.006
Dendritic cells in autoimmune disease
Radford, Kristen J., Shortman, Ken and O'Keefe, Meredith (2013). Dendritic cells in autoimmune disease. The autoimmune diseases. (pp. 175-186) edited by Noel R. Rose and Ian R. Mackay. San Diego, United States: Elsevier. doi: 10.1016/B978-0-12-384929-8.00012-5
Isolation of Human Blood DC Subtypes
Kassianos, Andrew J., Jongbloed, Sarah L., Hart, Derek N.J. and Radford, Kristen J. (2010). Isolation of Human Blood DC Subtypes. Dendritic cell protocols. (pp. 45-54) edited by Shalin H. Naik. New York, NY United States: Humana Press. doi: 10.1007/978-1-60761-421-0_3
Dendritic Cells in Cancer Immunotherapy
Vulink, A., Radford, K. J., Melief, C. and Hart, D. N. J. (2008). Dendritic Cells in Cancer Immunotherapy. Advances in Cancer Research. (pp. 363-407) London, U.K.: Elsevier Inc.. doi: 10.1016/S0065-230X(07)99006-5
Leung, Sherman S., Lenchik, Nataliya, Mathews, Clayton, Pugliese, Alberto, McCarthy, Domenica A., Le Bagge, Selena, Ewing, Adam, Harris, Mark, Radford, Kristen J., Borg, Danielle J., Gerling, Ivan and Forbes, Josephine M. (2023). Alpha cell receptor for advanced glycation end products associate with glucagon expression in type 1 diabetes. Scientific Reports, 13 (1) 12948, 1-15. doi: 10.1038/s41598-023-39243-x
Buckle, Irina, Johnson, Anthony, Rojas, Ingrid Leal, Weinert, Vicky, Sester, David P., Radford, Kristen and Guillerey, Camille (2023). High dimensional analysis reveals distinct NK cell subsets but conserved response to stimulation in umbilical cord blood and adult peripheral blood. European Journal of Immunology, 53 (6) 2250118, 1-13. doi: 10.1002/eji.202250118
CD4+ T cell calibration of antigen-presenting cells optimizes antiviral CD8+ T cell immunity
Gressier, Elise, Schulte-Schrepping, Jonas, Petrov, Lev, Brumhard, Sophia, Stubbemann, Paula, Hiller, Anna, Obermayer, Benedikt, Spitzer, Jasper, Kostevc, Tomislav, Whitney, Paul G., Bachem, Annabell, Odainic, Alexandru, van de Sandt, Carolien, Nguyen, Thi H. O., Ashhurst, Thomas, Wilson, Kayla, Oates, Clare V. L., Gearing, Linden. J., Meischel, Tina, Hochheiser, Katharina, Greyer, Marie, Clarke, Michele, Kreutzenbeck, Maike, Gabriel, Sarah S., Kastenmüller, Wolfgang, Kurts, Christian, Londrigan, Sarah L., Kallies, Axel, Kedzierska, Katherine ... Bedoui, Sammy (2023). CD4+ T cell calibration of antigen-presenting cells optimizes antiviral CD8+ T cell immunity. Nature Immunology, 24 (6), 979-990. doi: 10.1038/s41590-023-01517-x
Sikder, Md. Al Amin, Rashid, Ridwan B., Ahmed, Tufael, Sebina, Ismail, Howard, Daniel R., Ullah, Md. Ashik, Rahman, Muhammed Mahfuzur, Lynch, Jason P., Curren, Bodie, Werder, Rhiannon B., Simpson, Jennifer, Bissell, Alec, Morrison, Mark, Walpole, Carina, Radford, Kristen J., Kumar, Vinod, Woodruff, Trent M., Ying, Tan Hui, Ali, Ayesha, Kaiko, Gerard E., Upham, John W., Hoelzle, Robert D., Cuív, Páraic Ó., Holt, Patrick G., Dennis, Paul G. and Phipps, Simon (2023). Maternal diet modulates the infant microbiome and intestinal Flt3L necessary for dendritic cell development and immunity to respiratory infection. Immunity, 56 (5), 1098-1114.e10. doi: 10.1016/j.immuni.2023.03.002
Elahi, Zahra, Angel, Paul W., Butcher, Suzanne K., Rajab, Nadia, Choi, Jarny, Deng, Yidi, Mintern, Justine D., Radford, Kristen and Wells, Christine A. (2022). The Human Dendritic Cell Atlas: An Integrated Transcriptional Tool to Study Human Dendritic Cell Biology. Journal of Immunology, 209 (12), 2352-2361. doi: 10.4049/jimmunol.2200366
Elahi, Zahra, Angel, Paul W., Butcher, Suzanne K., Rajab, Nadia, Choi, Jarny, Deng, Yidi, Mintern, Justine D., Radford, Kristen and Wells, Christine A. (2022). The Human Dendritic Cell Atlas: an integrated transcriptional tool to study human dendritic cell biology. Journal of Immunology, 209 (12), 2352-2361. doi: 10.4049/jimmunol.2200366
Soluble RAGE Prevents Type 1 Diabetes Expanding Functional Regulatory T Cells
Leung, Sherman S., Borg, Danielle J., McCarthy, Domenica A., Boursalian, Tamar E., Cracraft, Justen, Zhuang, Aowen, Fotheringham, Amelia K., Flemming, Nicole, Watkins, Thomas, Miles, John J., Groop, Per-Henrik, Scheijen, Jean L., Schalkwijk, Casper G., Steptoe, Raymond J., Radford, Kristen J., Knip, Mikael and Forbes, Josephine M. (2022). Soluble RAGE Prevents Type 1 Diabetes Expanding Functional Regulatory T Cells. Diabetes, 71 (9), 1994-2008. doi: 10.2337/db22-0177
Pang, Ee Shan, Daraj, Ghazal, Balka, Katherine R., De Nardo, Dominic, Macri, Christophe, Hochrein, Hubertus, Masterman, Kelly-Anne, Tan, Peck S., Shoppee, Angus, Magill, Zoe, Jahan, Nazneen, Bafit, Mariam, Zhan, Yifan, Kile, Benjamin T., Lawlor, Kate E., Radford, Kristen J., Wright, Mark D. and O'Keeffe, Meredith (2022). Discordance in STING-induced activation and cell death between mouse and human dendritic cell populations. Frontiers in Immunology, 13 794776. doi: 10.3389/fimmu.2022.794776
DROSHA but not DICER is required for human haematopoietic stem cell function
Gu, Karen, Walpole, Carina, Gooneratne, Shayarana, Liu, Xin, Haigh, Oscar L., Radford, Kristen J. and Chong, Mark M. W. (2022). DROSHA but not DICER is required for human haematopoietic stem cell function. Clinical and Translational Immunology, 11 (1) e1361, e1361. doi: 10.1002/cti2.1361
Conventional Type 1 dendritic cells (cDC1) as cancer therapeutics: challenges and opportunities
Johnson, Phillip, Rosendahl, Nikita and Radford, Kristen J. (2021). Conventional Type 1 dendritic cells (cDC1) as cancer therapeutics: challenges and opportunities. Expert Opinion on Biological Therapy, 22 (4), 1-8. doi: 10.1080/14712598.2022.1994943
Cytokines as a marker of central nervous system autoantibody associated epilepsy
Gillinder, Lisa, McCombe, Pamela, Powell, Tamara, Hartel, Gunter, Gillis, David, Rojas, Ingrid Leal and Radford, Kristen (2021). Cytokines as a marker of central nervous system autoantibody associated epilepsy. Epilepsy Research, 176 106708, 1-7. doi: 10.1016/j.eplepsyres.2021.106708
Li, Jessica, Panetta, Fatma, O’Keeffe, Meredith, Leal Rojas, Ingrid M., Radford, Kristen J., Zhang, Jian-Guo, Fernandez-Ruiz, Daniel, Davey, Gayle M., Gully, Benjamin S., Tullett, Kirsteen M., Rossjohn, Jamie, Berry, Richard, Lee, Chin-Nien, Lahoud, Mireille H., Heath, William R. and Caminschi, Irina (2021). Elucidating the motif for CpG oligonucleotide binding to the dendritic cell receptor DEC-205 leads to improved adjuvants for liver-resident memory. The Journal of Immunology, 207 (7), 1836-1847. doi: 10.4049/jimmunol.2001153
Forbes, Josephine M., McCarthy, Domenica A., Kassianos, Andrew J., Baskerville, Tracey, Fotheringham, Amelia J., Giuliani, Kurt T. K., Grivei, Anca, Murphy, Andrew J., Flynn, Michelle C., Sullivan, Mitchell A., Chandrashekar, Preeti, Whiddett, Rani, Radford, Kristen J., Flemming, Nicole, Beard, Sam S., D’Silva, Neisha, Nisbet, Janelle, Morton, Adam, Teasdale, Stephanie, Russell, Anthony, Isbel, Nicole, Jones, Timothy, Couper, Jennifer, Healy, Helen, Harris, Mark, Donaghue, Kim, Johnson, David W., Cotterill, Andrew, Barrett, Helen L. and O’Moore-Sullivan, Trisha (2021). T cell expression and release of kidney injury molecule-1 in response to glucose variations initiates kidney injury in early diabetes. Diabetes, 70 (8), 1754-1766. doi: 10.2337/db20-1081
Pang, Ee Shan, Daraj, Ghazal, Macri, Christophe, Balka, Katherine, de Nardo, Dominic, Hochrein, Hubertus, Masterman, Kelly-Anne, Zhan, Yifan, Kile, Benjamin, Lawlor, Kate, Radford, Kristen, Wright, Mark and O’Keeffe, Meredith (2021). Activation of stimulator of interferon genes in dendritic cells induces interferon-lambda and subset- and species-specific dendritic cell death. The Journal of Immunology, 206 (1_Supplement), 111.28-111.28. doi: 10.4049/jimmunol.206.supp.111.28
Adhesion to E-selectin primes macrophages for activation through AKT and mTOR
Davies, Julie M., Radford, Kristen J., Begun, Jakob, Levesque, Jean-Pierre and Winkler, Ingrid G. (2021). Adhesion to E-selectin primes macrophages for activation through AKT and mTOR. Immunology and Cell Biology, 99 (6) imcb.12447, 622-639. doi: 10.1111/imcb.12447
Lee, Yoke Seng, O'Brien, Liam J., Walpole, Carina M., Pearson, Frances E., Leal-Rojas, Ingrid M., Masterman, Kelly-Anne, Atkinson, Victoria, Barbour, Andrew and Radford, Kristen J. (2021). Human CD141+ dendritic cells (cDC1) are impaired in patients with advanced melanoma but can be targeted to enhance anti-PD-1 in a humanized mouse model. Journal for ImmunoTherapy of Cancer, 9 (3) e001963, 1-12. doi: 10.1136/jitc-2020-001963
Enhancing the immunogenicity of cancer vaccines by harnessing CLEC9A
Lahoud, M. H. and Radford, K. J. (2021). Enhancing the immunogenicity of cancer vaccines by harnessing CLEC9A. Human Vaccines and Immunotherapeutics, 18 (1) 1873056, 1-5. doi: 10.1080/21645515.2021.1873056
Tullett, Kirsteen M., Tan, Peck Szee, Park, Hae-Young, Schittenhelm, Ralf B., Michael, Nicole, Li, Rong, Policheni, Antonia N., Gruber, Emily, Huang, Cheng, Fulcher, Alex J., Danne, Jillian C., Czabotar, Peter E., Wakim, Linda M., Mintern, Justine D., Ramm, Georg, Radford, Kristen J., Caminschi, Irina, O'Keeffe, Meredith, Villadangos, Jose A., Wright, Mark D., Blewitt, Marnie E., Heath, William R., Shortman, Ken, Purcell, Anthony W., Nicola, Nicos A., Zhang, Jian-Guo and Lahoud, Mireille H. (2020). RNF41 regulates the damage recognition receptor Clec9A and antigen cross-presentation in mouse dendritic cells. eLife, 9 e63452, 1-31. doi: 10.7554/eLife.63452
Masterman, Kelly-Anne, Haigh, Oscar L., Tullett, Kirsteen M., Leal-Rojas, Ingrid M., Walpole, Carina, Pearson, Frances E., Cebon, Jonathon, Schmidt, Christopher, O'Brien, Liam, Rosendahl, Nikita, Daraj, Ghazal, Caminschi, Irina, Gschweng, Eric H., Hollis, Roger P., Kohn, Donald B., Lahoud, Mireille H. and Radford, Kristen J. (2020). Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141+ dendritic cells to activate naïve and memory NY-ESO-1-specific CD8+ T cells. Journal for ImmunoTherapy of Cancer, 8 (2) e000691, 1-11. doi: 10.1136/jitc-2020-000691
Pearson, Frances E., Tullett, Kirsteen M., Leal-Rojas, Ingrid M., Haigh, Oscar L., Masterman, Kelly-Anne, Walpole, Carina, Bridgeman, John S., McLaren, James E., Ladell, Kristin, Miners, Kelly, Llewellyn-Lacey, Sian, Price, David A., Tunger, Antje, Schmitz, Marc, Miles, John J., Lahoud, Mireille H. and Radford, Kristen J. (2020). Human CLEC9A antibodies deliver Wilms' tumor 1 (WT1) antigen to CD141+ dendritic cells to activate naïve and memory WT1-specific CD8+ T cells. Clinical and Translational Immunology, 9 (6) e1141, e1141. doi: 10.1002/cti2.1141
MUC13 promotes the development of colitis-associated colorectal tumors via β-catenin activity
Sheng, Yong Hua, Wong, Kuan Yau, Seim, Inge, Wang, Ran, He, Yaowu, Wu, Andy, Patrick, Maya, Lourie, Rohan, Schreiber, Veronika, Giri, Rabina, Ng, Choa Ping, Popat, Amirali, Hooper, John, Kijanka, Gregor, Florin, Timothy H., Begun, Jakob, Radford, Kristen J., Hasnain, Sumaira and McGuckin, Michael A. (2019). MUC13 promotes the development of colitis-associated colorectal tumors via β-catenin activity. Oncogene, 38 (48), 7294-7310. doi: 10.1038/s41388-019-0951-y
Can Dendritic Cell vaccination prevent leukemia relapse?
O’Brien, Liam J., Guillerey, Camille and Radford, Kristen J. (2019). Can Dendritic Cell vaccination prevent leukemia relapse?. Cancers, 11 (6) 875, 875. doi: 10.3390/cancers11060875
Simple, rapid and inexpensive typing of common HLA class I alleles for immunological studies
Law, Soi Cheng, Haigh, Oscar L., Walpole, Carina M., Keane, Colm, Miles, John, Gandhi, Maher K., Radford, Kristen J. and Steptoe, Raymond J. (2019). Simple, rapid and inexpensive typing of common HLA class I alleles for immunological studies. Journal of Immunological Methods, 465, 72-76. doi: 10.1016/j.jim.2018.12.002
Pearson, Frances E., Chang, Karshing, Minoda, Yoshihito, Leal Rojas, Ingrid M., Haigh, Oscar L., Daraj, Ghazal, Tullett, Kirsteen M. and Radford, Kristen J. (2018). Activation of human CD141+ and CD1c+ dendritic cells in vivo with combined TLR 3 and TLR 7/8 ligation. Immunology and Cell Biology, 96 (4), 390-400. doi: 10.1111/imcb.12009
Minoda, Yoshihito, Virshup, Isaac, Rojas, Ingrid Leal, Haigh, Oscar, Wong, Yide, Miles, John J., Wells, Christine A. and Radford, Kristen J. (2017). Human CD141(+) dendritic cell and CD1c(+) dendritic cell undergo concordant early genetic programming after activation in humanized mice in vivo. Frontiers in Immunology, 8 (OCT) 1419, 1419. doi: 10.3389/fimmu.2017.01419
Human blood cD1c+ dendritic cells promote Th1 and Th17 effector function in memory cD4+ T cells
Rojas, Ingrid M. Leal, Mok, Wai-Hong, Pearson, Frances E., Minoda, Yoshihito, Kenna, Tony J., Barnard, Ross T. and Radford, Kristen J. (2017). Human blood cD1c+ dendritic cells promote Th1 and Th17 effector function in memory cD4+ T cells. Frontiers in Immunology, 8 (AUG) 971, 971. doi: 10.3389/fimmu.2017.00971
Targeting CLEC9A delivers antigen to human CD141+ DC for CD4+ and CD8+ T cell recognition
Tullett, Kirsteen M., Leal Rojas, Ingrid M., Minoda, Yoshihito, Tan, Peck S., Zhang, Jian-Guo, Smith, Corey, Khanna, Rajiv, Shortman, Ken, Caminschi, Irina, Lahoud, Mireille H. and Radford, Kristen J. (2016). Targeting CLEC9A delivers antigen to human CD141+ DC for CD4+ and CD8+ T cell recognition. JCI Insight, 1 (7) e87102, e87102. doi: 10.1172/jci.insight.87102
T cell receptor reversed polarity recognition of a self-antigen major histocompatibility complex
Beringer, Dennis X., Kleijwegt, Fleur S., Wiede, Florian, Van Der Slik, Arno R., Loh, Khai Lee, Petersen, Jan, Dudek, Nadine L., Duinkerken, Gaby, Laban, Sandra, Joosten, Antoinette, Vivian, Julian P., Chen, Zhenjun, Uldrich, Anthony W., Godfrey, Dale I., McCluskey, James, Price, David A., Radford, Kristen J., Purcell, Anthony W., Nikolic, Tatjana, Reid, Hugh H., Tiganis, Tony, Roep, Bart O. and Rossjohn, Jamie (2015). T cell receptor reversed polarity recognition of a self-antigen major histocompatibility complex. Nature Immunology, 16 (11), 1153-1161. doi: 10.1038/ni.3271
Human dendritic cell subsets and function in health and disease
O'Keeffe, Meredith., Mok, Wai Hong. and Radford, Kristen J. (2015). Human dendritic cell subsets and function in health and disease. Cellular and Molecular Life Sciences, 72 (22), 4309-4325. doi: 10.1007/s00018-015-2005-0
Differential use of autophagy by primary dendritic cells specialized in cross-presentation
Mintern, Justine D., Macri, Christophe, Chin, Wei Jin, Panozza, Scott E., Segura, Elodie, Patterson, Natalie L., Zeller, Peter, Bourges, Dorothee, Bedoui, Sammy, McMillan, Paul J., Idris, Adi, Nowell, Cameron J., Brown, Andrew, Radford, Kristen J., Johnston, Angus P. R. and Villadangos, Jose A. (2015). Differential use of autophagy by primary dendritic cells specialized in cross-presentation. Autophagy, 11 (6), 906-917. doi: 10.1080/15548627.2015.1045178
Prue, Rebecca L., Vari, Frank, Radford, Kristen J., Tong, Hui, Hardy, Melinda Y., D'Rozario, Rachael, Waterhouse, Nigel J., Rossetti, Tony, Coleman, Robert, Tracey, Christopher, Goossen, Hans, Gounder, Vinay, Crosbie, Georgina, Hancock, Sonia, Diaz-Guilas, Stephanie, Mainwaring, Paul, Swindle, Peter and Hart, Derek N. J. (2015). A phase I clinical trial of CD1c (BDCA-1)+ dendritic cells pulsed with HLA-A*0201 peptides for immunotherapy of metastatic hormone refractory prostate cancer. Journal of Immunotherapy, 38 (2), 71-76. doi: 10.1097/CJI.0000000000000063
Differential uptake and cross-presentation of soluble and necrotic cell antigen by human DC subsets
Chiang, Meng-Chieh, Tullett, Kirsteen M., Lee, Yoke Seng, Idris, Adi, Ding, Yitian, McDonald, Kylie J., Kassianos, Andrew, Leal Rojas, Ingrid M., Jeet, Varinder, Lahoud, Mireille H. and Radford, Kristen J. (2015). Differential uptake and cross-presentation of soluble and necrotic cell antigen by human DC subsets. European Journal of Immunology, 46 (2), 329-339. doi: 10.1002/eji.201546023
Harnessing human cross-presenting CLEC9A+XCR1+ dendritic cells for immunotherapy
Tullett, Kirsteen M., Lahoud, Mireille H. and Radford, Kristen J. (2014). Harnessing human cross-presenting CLEC9A+XCR1+ dendritic cells for immunotherapy. Frontiers in Immunology, 5 (MAY) Article 239, 1-1. doi: 10.3389/fimmu.2014.00239
Dendritic cells and cancer immunotherapy
Radford, Kristen J., Tullett, Kirsteen M. and Lahoud, Mireille H. (2014). Dendritic cells and cancer immunotherapy. Current Opinion in Immunology, 27 (1), 26-32. doi: 10.1016/j.coi.2014.01.005
Ding, Yitian, Wilkinson, Andrew, Idris, Adi, Fancke, Ben, O’Keeffe, Meredith, Khalil, Dalia, Ju, Xinsheng, Lahoud, Mireille H., Caminschi, Irina, Shortman, Ken, Rodwell, Robyn, Vuckovic, Slavica and Radford, Kristen J. (2014). FLT3-ligand treatment of humanized mice results in the generation of large numbers of CD141+ and CD1c+ dendritic cells in vivo. Journal of Immunology. doi: 10.4049/jimmunol.1302391
New generation of dendritic cell vaccines
Radford, Kristen J. and Caminschi, Irina (2013). New generation of dendritic cell vaccines. Human Vaccines and Immunotherapeutics, 9 (2), 259-264. doi: 10.4161/hv.22487
Mincle polarizes human monocyte and neutrophil responses to Candida albicans
Vijayan, Dipti, Radford, Kristen J., Beckhouse, Anthony G., Ashman, Robert B. and Wells, Christine A. (2012). Mincle polarizes human monocyte and neutrophil responses to Candida albicans. Immunology and Cell Biology, 90 (9), 889-895. doi: 10.1038/icb.2012.24
Kassianos, Andrew J., Hardy, Melinda Y., Ju, Xinsheng, Vijayan, Dipti, Ding, Yitian, Vulink, Annelie J. E., McDonald, Kylie J., Jongbloed, Sarah L., Wadley, Robert B., Wells, Christine, Hart, Derek N. J. and Radford, Kristen J. (2012). Human CD1c (BDCA-1)+ myeloid dendritic cells secrete IL-10 and display an immuno-regulatory phenotype and function in response to Escherichia coli. European Journal of Immunology, 42 (6), 1512-1522. doi: 10.1002/eji.201142098
Wilkinson, Ray, Woods, Katherine, D’Rozario, Rachael, Prue, Rebecca, Vari, Frank, Hardy, Melinda Y., Dong, Ying, Clements, Judith A., Hart, Derek N.J. and Radford, Kristen J. (2012). Human kallikrein 4 signal peptide induces cytotoxic T cell responses in healthy donors and prostate cancer patients. Cancer Immunology, Immunotherapy, 61 (2), 169-179. doi: 10.1007/s00262-011-1095-2
Cullup, Hannah, Hsu, Andy K. W., Kassianos, Andrew J., McDonald, Kylie, Radford, Kristen J. and Rice, Alison M. (2011). CD34+ cord blood DC-induced antitumor lymphoid cells have efficacy in a murine xenograft model of human ALL. Journal of Immunotherapy, 34 (4), 362-371. doi: 10.1097/CJI.0b013e31821b7230
Jongbloed, Sarah L., Kassianos, Andrew J., McDonald, Kylie J., Clark, Georgina J., Ju, Xinsheng, Angel, Catherine E., Chen, Chun-Jen J., Dunbar, P. Rod, Wadley, obert B., Jeet, Varinder, Vulink, Annelie J.E., Hart, Derek N.J. and Radford, Kristen J. (2010). Human CD141(+) (BDCA-3)(+) dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. Journal of Experimental Medicine, 207 (6), 1247-1260. doi: 10.1084/jem.20092140
NK cells enhance the induction of CTL responses by IL-15 monocyte-derived dendritic cells
Hardy, M., Kassianos, A., Vulink, A., Wilkinson, R., Jongbloed, S. L., Hart, D. N. J. and Radford, K. J. (2009). NK cells enhance the induction of CTL responses by IL-15 monocyte-derived dendritic cells. Immunology and Cell Biology, 87 (8), 606-614. doi: 10.1038/icb.2009.44
Wilson, John, Cullup, Hannah, Lourie, Rohan, Sheng, Yonghua, Palkova, Anna, Radford, Kristen J., Dickinson, Anne M., Rice, Alison M., Hart, Derek N.J. and Munster, David J. (2009). Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host disease: Figure 6. The Journal of Experimental Medicine, 206 (5), 1203-1203. doi: 10.1084/jem.20070723041509c
Wilson, John, Cullup, Hannah, Lourie, Rohan, Sheng, Yonghua, Palkova, Anna, Radford, Kristen J., Dickinson, Anne M., Rice, Alison M., Hart, Derek N. J. and Munster, David J. (2009). Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host disease. Journal of Experimental Medicine, 206 (2), 387-398. doi: 10.1084/jem.20070723
McKinlay, Adam, Radford, Kristen, Kato, Masato, Field, Ken, Gardiner, Damien, Khalil, Dalia, Burnell, Fiona, Hart, Derek and Vuckovic, Slavica (2007). Blood monocytes, myeloid dendritic cells and the cytokines interleukin (IL)-7 and IL-15 maintain human CD4(+) T memory cells with mixed helper/regulatory function. Immunology, 120 (3), 392-403. doi: 10.1111/j.1365-2567.2006.02515.x
Badiee, A., Davies, N. M., McDonald, K., Radford, K., Michiue, H., Hart, D. and Kato, M. (2007). Enhanced delivery of immunoliposomes to human dendritic cells by targeting the multilectin receptor DEC-205. Vaccine, 25 (25), 4757-4766. doi: 10.1016/j.vaccine.2007.04.029
Numerical and functional assessment of blood dendritic cells in prostate cancer patients
Wilkinson, Ray, Kassianos, Andrew J., Swindle, Peter, Hart, Derek N. J. and Radford, Kristen J. (2006). Numerical and functional assessment of blood dendritic cells in prostate cancer patients. The Prostate, 66 (2), 180-192. doi: 10.1002/pros.20333
Radford, Kristen J., Turtle, Cameron J., Kassianos, Andrew J. and Hart, Derek N. J. (2006). CD11c+ blood dendritic cells induce antigen-specific cytotoxic T lymphocytes with similar efficiency compared to monocyte-derived dendritic cells despite higher levels of MHC class I expression. Journal of Immunotherapy, 29 (6), 596-605. doi: 10.1097/01.cji.0000211310.90621.5d
Vaccine strategies to treat lymphoproliferative disorders
Radford, Kristen J., Vari, Frank and Hart, Derek N. J. (2005). Vaccine strategies to treat lymphoproliferative disorders. Pathology, 37 (6), 534-550. doi: 10.1080/00313020500376462
Radford, Kristen J., Turtle, Cameron J., Kassianos, Andrew J., Vuckovic, Slavica, Gardiner, Damien, Khalil, Dahlia, Taylor, Kerry, Wright, Sue, Gill, Devinder and Hart, Derek N. J. (2005). Immunoselection of functional CMRF-56+ blood dendritic cells from multiple myeloma patients for immunotherapy. Journal of Immunotherapy, 28 (4), 322-331. doi: 10.1097/01.cji.0000163592.66910.e4
Potential therapeutic applications of recombinant, invasive E. coli
Critchley, R, Jezzard, S, Radford, KJ, Goussard, S, Lemoine, NR, Grillot-Courvalin, C and Vassaux, G (2004). Potential therapeutic applications of recombinant, invasive E. coli. Gene Therapy, 11 (15), 1224-1233. doi: 10.1038/sj.gt.3302281
Radford, KJ, Jackson, AM, Wang, JH, Vassaux, G and Lemoine, NR (2003). Recombinant E. coli efficiently delivers antigen and maturation signals to human dendritic cells: Presentation of MART1 to CD8+ T cells. International Journal of Cancer, 105 (6), 811-819. doi: 10.1002/ijc.11149
Radford, K. J., Higgins, D. E., Pasquini, S., Cheadle, E. J., Carta, L., Jackson, A. M., Lemoine, N. R. and Vassaux, G. (2002). A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: application to cancer immunotherapy. Gene Therapy, 9 (21), 1455-1463. doi: 10.1038/sj.gt.3301812
Immunogenicity of CD63 in a patient with melanoma
Smith, Melanie, Bleijs, Rik, Radford, Kristen and Mersey, Peter (1997). Immunogenicity of CD63 in a patient with melanoma. Melanoma Research, 7 (SUPPL. 2)
Regulation of tumor cell motility and migration by CD63 in a human melanoma cell line
Radford, KJ, Thorne, RF and Hersey, P (1997). Regulation of tumor cell motility and migration by CD63 in a human melanoma cell line. Journal of Immunology, 158 (7), 3353-3358.
Radford, KJ, Thorne, RF and Hersey, P (1996). CD63 associates with transmembrane 4 superfamily members, CD9 and CD81, and with β1 integrins in human melanoma. Biochemical and Biophysical Research Communications, 222 (1), 13-18. doi: 10.1006/bbrc.1996.0690
Radford, KJ, Mallesch, J and Hersey, P (1995). Suppression of human melanoma cell growth and metastasis by the melanoma-associated antigen CD63 (ME491). International Journal of Cancer, 62 (5), 631-635. doi: 10.1002/ijc.2910620523
Targeting human CD141+DC using CLEC9A antibodies for cancer immunotherapy
Masterman, K-A., Pearson, F. E., Tullett, K., Haigh, O., Walpole, C., Daraj, G., Lahoud, M. H., Rojas, I. Leal and Radford, K. (2018). Targeting human CD141+DC using CLEC9A antibodies for cancer immunotherapy. ESMO Immuno-Oncology Congress, Geneva Switzerland, Dec 13-16, 2018. OXFORD: OXFORD UNIV PRESS.
Characterising the effects of interferon lambda on dendritic cell function and activation
Pang, E. S., Macri, C., Lundie, R., Pooley, J., Gearing, J., Pupovac, A., Jacobson, K., Hertzog, P., Hochrein, H., Radford, K. and O'Keeffe, M. (2018). Characterising the effects of interferon lambda on dendritic cell function and activation. 15th International Symposium on Dendritic Cells (DC), Aachen Germany, Jun 10-14, 2018. HOBOKEN: WILEY.
Targeting human CD141(+) DC using CLEC9A antibodies for cancer immunotherapy
Pearson, F., Masterman, K. A., Tullett, K., Haigh, O., Walpole, C., Daraj, G., Rojas, Leal, Lahoud, M. H. and Radford, K. (2018). Targeting human CD141(+) DC using CLEC9A antibodies for cancer immunotherapy. 15th International Symposium on Dendritic Cells (DC), Aachen Germany, Jun 10-14, 2018. Hoboken, NJ United States: Wiley.
Characterising the effects of interferon lambda on dendritic cells
Pang, E. S., Macri, C., Pooley, J., Fancke, B., Lundie, R., Hochrein, H., Radford, K. and O'Keeffe, M. (2016). Characterising the effects of interferon lambda on dendritic cells. International Congress of Immunology (ICI), Melbourne Australia, Aug 21-26, 2016. HOBOKEN: WILEY-BLACKWELL.
Enhanced activation of human CD141(+) DC and CD1c(+) DC in vivo with combined TLR3/TLR8 ligation
Chang, K., Minoda, Y., Leal Rojas, I, Tullett, K. and Radford, K. (2016). Enhanced activation of human CD141(+) DC and CD1c(+) DC in vivo with combined TLR3/TLR8 ligation. International Congress of Immunology (ICI), Melbourne, VIC, Australia, 21-26 August, 2016. Weinheim, Germany: Wiley.
Yap, X. Z., Lundie, R. J., Macri, C. F., Rojas, Leal, I, Feng, G., Radford, K. J., Beeson, J. G. and O'Keeffe, M. (2016). Human dendritic cell interactions with P-falciparum provide insight into the development of host immunity to malaria. International Congress of Immunology (ICI), Melbourne Australia, Aug 21-26, 2016. HOBOKEN: WILEY-BLACKWELL.
Tan, P. S., Tullett, K., Park, H-Y, Gruber, E., Radford, K., Nicola, N., Zhang, J-G, Shortman, K., Caminschi, I and Lahoud, M. (2016). Molecular basis for the efficient processing of antigens taken up by Clec9A, a DAMP receptor on dendritic cells. International Congress of Immunology (ICI), Melbourne Australia, Aug 21-26, 2016. HOBOKEN: WILEY-BLACKWELL.
Tullett, K. M., Leal Rojas, I. M., Minoda, Y., Tan, P. S., Zhang, J. -G, Smith, C., Khanna, R., Shortman, K., Caminschi, I, Lahoud, M. H. and Radford, K. J. (2016). Targeting CLEC9A can deliver antigen to human CD141(+) DC for recognition by both CD4(+) and CD8(+) T cells. International Congress of Immunology (ICI), Melbourne, VIC, Australia, 21-26 August, 2016. Weinheim, Germany: Wiley.
Winkler, Ingrid G., Barbier, Valerie, Radford, Kristen J., Davies, Julie M., Levesque, Jean-Pierre, Smith, Theodore A. G., Fogler, William E. and Magnani, John L. (2015). Mobilization of CD8(+) Central Memory T-Cells with Enhanced Reconstitution Potential in Mice By a Combination of G-CSF and GMI-1271-Mediated E-Selectin Blockade. 57th Annual Meeting of the American Society of Hematology, Orlando, FL United States, 5-8 December 2015. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood.V126.23.512.512
Gandhi, MK, Hertzberg, MS, Han, E, Seymour, JF, Hicks, R, Gill, DS, Keane, C, Crooks, P, Radford, K and Vari, F (2011). Monocytes Are Associated with Impaired T-Cell Immunity and Residual Interim-PET/CT Avidity After 4 Cycles of CHOP-R In Patients with High-Risk DLBCL. 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), San Diego Ca, Dec 10-13, 2011. WASHINGTON: AMER SOC HEMATOLOGY.
CD83 antibody prevents GvHD and does not impair GvL induction
Cullup, H., Wilson, J., Lourie, R., Shen, Y., Palkova, A., Radford, K., Dickinson, A. M., Rice, A., Hart, D. and Munster, D. (2009). CD83 antibody prevents GvHD and does not impair GvL induction. 35th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Goteborg Sweden, Mar 29-Apr 01, 2009. LONDON: NATURE PUBLISHING GROUP.
Hardy, Melinda Y., Kassianos, Andrew J., Wilkinson, Ray, Vulink, Anneie, Hart, Derek N. J. and Radford, Kristen J. (2007). Residual lymphocytes in GM-CSF and IL-15 differentiated monocyte-derived dendritic cells enables cytotoxic T lymphocyte responses. 49th Annual Meeting of the American-Society-of-Hematology, Atlanta Ga, Dec 08-11, 2007. WASHINGTON: AMER SOC HEMATOLOGY.
Mckinlay, A, Radford, KJ, Gardiner, D, Khalil, D, Field, K, Burnell, F, Hart, DNJ and Vuckovic, S (2005). Human memory CD4(+) T cells maintained in the absence of antigen develop regulatory T cells capable of suppressing antibody responses. 35th Annual SCientific Meeting of the Australasian-Society-for-Immunology/14th International HLA and Immunogenetics Workshops, Melbourne Australia, Nov 29-Dec 02, 2005. OXFORD: BLACKWELL PUBLISHING.
Production of IL-2, IL-12, and IL-10 by human blood myeloid dendritic cells
Hardy, MY, Kassianos, AJ, Clark, GJ, Hart, DNJ and Radford, KJ (2005). Production of IL-2, IL-12, and IL-10 by human blood myeloid dendritic cells. 35th Annual SCientific Meeting of the Australasian-Society-for-Immunology/14th International HLA and Immunogenetics Workshops, Melbourne Australia, Nov 29-Dec 02, 2005. OXFORD: BLACKWELL PUBLISHING.
Turtle, C. J., Radford, K. J., Allan, C. P., Kassianos, A., Kato, M., Vuckovic, S., MacDonald, K.J., Lopez, Jose A., Jackson, D. C., Wright, S., Taylor, K., Marlton, P., Gill, D., Hart, D. N. J. and Korngold, R. (2004). RNA-loading of CMRF-56 positive blood dendritic cells is a promising strategy for multiple myeloma immunotherapy. Tandem BMT 2004 Meeting, Orlando, Florida, U.S., 13-17 February 2004. CHARLOTTESVILLE: AMER SOC HEMATOLOGY. doi: 10.1016/j.bbmt.2003.12.081
Turtle, CJ, Radford, KJ, Allan, CP, Kato, M and Hart, DNJ (2003). RNA-loading of CMRF-56 positive blood dendritic cells is a promising strategy for multiple myeloma immunotherapy.. 45th Annual Meeting of the American-Society-of-Hematology, San Diego California, Dec 06-09, 2003. WASHINGTON: AMER SOC HEMATOLOGY.
New immunotherapeutics for Acute Myeloid Leukemia
(2021–2022) TdC Senior Research Grant
New strategies to alleviate the effects of chemotherapy in children with leukemia
(2020–2022) The Children's Hospital Foundation
Novel human preclinical tools to better predict outcomes for immunotherapy
(2020–2022) Children's Hospital Foundation Immunotherapy Research Grants
(2020–2022) Children's Hospital Foundation Immunotherapy Research Grants
Unleashing natural killer cell activity against childhood leukemia
(2020–2022) The Children's Hospital Foundation
Engineering human dendritic cells for tolerogenic gene therapy of type 1 diabetes
(2019–2022) NHMRC Project Grant
(2017–2020) St Vincent's Institute of Medical Research
Developing novel immunotherapies for childhood blood cancers using advanced, humanised mouse models.
(2017–2018) The Kids' Cancer Project
(2016–2018) University of Miami
(2016–2018) The Children's Hospital Foundation
Clec9A Targeting Antibodies as a New Immunotherapy for Prostate Cancer
(2015–2019) United States Congressionally Directed Medical Research Programs - Prostate Cancer Research Program
A new approach to the design and evaluation of T cell vaccines for cancer and infectious disease.
(2015–2017) NHMRC Project Grant
(2015–2017) Monash University
Targeting human CLEC9A+ dendritic cells as a new strategy for cancer immunotherapy
(2015–2017) Worldwide Cancer Research
(2013–2014) NHMRC Career Development Fellowship
Development of novel vaccines for cancer immunotherapy
Doctor Philosophy — Principal Advisor
Other advisors:
Immune cell regulation by the microenvironment
Doctor Philosophy — Associate Advisor
Other advisors:
Defining the Clinical Phenotype of Autoantibody Associated Epilepsy
Doctor Philosophy — Associate Advisor
Other advisors:
Targeting antigens to DC for tolerance induction in a humanized mouse model
Doctor Philosophy — Associate Advisor
Investigations in the development of cord blood derived, GMP grade cellular immunotherapies
Doctor Philosophy — Associate Advisor
Other advisors:
Personalised therapy for lymphoma
Doctor Philosophy — Associate Advisor
Other advisors:
Establishing Humanized Mouse Models to Evaluate Immunotherapy
(2022) Doctor Philosophy — Principal Advisor
Other advisors:
Human dendritic cell immunoprofiling in advanced melanoma patients and responses to immunotherapy
(2019) Doctor Philosophy — Principal Advisor
Other advisors:
Molecular characterisation and targeting of the dendritic cell receptor Clec9A
(2016) Doctor Philosophy — Principal Advisor
The role of human CD1c+ dendritic cells at activating innate and adaptive cells of the immune system
(2016) Master Philosophy — Principal Advisor
Other advisors:
Development of humanised mouse model for DC based immunotherapy
(2015) Master Philosophy — Principal Advisor
The functional characterisation of human blood CD11c+ myeloid dendritic cell subsets
(2010) Doctor Philosophy — Principal Advisor
(2008) Doctor Philosophy — Principal Advisor
Understanding the early inflammatory response to traumatic spinal cord injury
(2022) Doctor Philosophy — Associate Advisor
Other advisors:
The role of receptor for advanced glycation end products (RAGE) in the development of type 1 diabetes
(2020) Doctor Philosophy — Associate Advisor
Other advisors:
CD83 as a Drug Target in GVHD and Humoral Immunity
(2015) Doctor Philosophy — Associate Advisor
The role of Mincle in the human innate immune response to Candida albicans
(2013) Doctor Philosophy — Associate Advisor
Other advisors: